<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="GBP" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-GOV-10-GAMRIF-WP6-GARDP-2019-2022</iati-identifier>
  <reporting-org ref="GB-GOV-10" type="10">
   <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Global Antimicrobial Resistance Innovation Fund (GAMRIF) - New Antibiotic for Drug-Resistant Gonorrhoea with GARDP</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The Global Antibiotic Research &amp; Development Partnership (GARDP) is a non-profit product development partnership in association with the World Health Organisation (WHO). It is a research and development initiative addressing global public health needs by developing, delivering and assuring sustainable access of new or improved antibiotic treatments. UK Department of Health and Social Care (DHSC) funding through the Global AMR Innovation Fund (GAMRIF) will support GARDP&#x2019;s programme on sexually transmitted infections (STI), specifically focusing on the development of a new antibiotic for drug-resistant gonorrhoea. The aim of this project is to fund and support the development of new treatments that address the threat of drug-resistant gonorrhoea in low- and middle- income countries (LMICs). Objectives of the funded activity are to: - develop a new affordable treatment for gonorrhoea, that works on multi-drug resistant cases (trials completed and registration started by 2022) - support the integration of the new treatments into the current Sexually Transmitted Infection management framework by investigating possible antibiotic combinations by 2023 - develop a new stewardship and access strategy by 2022. Projects funded through GAMRIF will primarily benefit people in LMICs, where the burden of drug-resistant infection is greater.</narrative>
  </description>
  <participating-org role="4" type="21">
   <narrative xml:lang="EN">The Global Antibiotic Research &amp; Development Partnership (GARDP)</narrative>
  </participating-org>
  <participating-org ref="GB-GOV-10" role="1" type="10">
   <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
  </participating-org>
  <participating-org ref="GB-GOV-10" role="2" type="10">
   <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-07-01" type="1"></activity-date>
  <activity-date iso-date="2019-07-01" type="2"></activity-date>
  <activity-date iso-date="2022-03-31" type="3"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">Department of Health and Social Care (DHSC)</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">The UK&apos;s Department of Health and Social Care (DHSC) helps people to live more independent, healthier lives for longer. Our official development assistance (ODA) funded programmes take this objective beyond the UK to address global health challenges for the benefit of people living in low- and middle-income countries (LMICs).</narrative>
   </department>
   <telephone>0207 210 4850</telephone>
   <mailing-address>
    <narrative xml:lang="EN">Department of Health and Social Care, 39 Victoria Street, London, SW1H 0EU</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="13040" percentage="100" vocabulary="1"></sector>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2019-07-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="GBP" value-date="2019-07-01">1503218</value>
  </budget>
  <budget status="1" type="1">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-09-30"></period-end>
   <value currency="GBP" value-date="2020-04-01">677240</value>
  </budget>
  <budget status="1" type="1">
   <period-start iso-date="2020-10-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="GBP" value-date="2020-10-01">551474</value>
  </budget>
  <budget status="1" type="1">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="GBP" value-date="2021-04-01">374880</value>
  </budget>
  <budget status="1" type="1">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="GBP" value-date="2021-10-01">393187</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-10-25"></transaction-date>
   <value currency="GBP" value-date="2019-10-25">3500000</value>
   <provider-org provider-activity-id="GB-GOV-10-GAMRIF-WP6-GARDP-2019-2022" ref="GB-GOV-10" type="10">
    <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
   </provider-org>
   <receiver-org ref="GB-GOV-10-GAMRIF-WP6-GARDP-2019-2022">
    <narrative xml:lang="EN">Global Antibiotic Research &amp; Development Partnership (GARDP)</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-12"></transaction-date>
   <value currency="GBP" value-date="2020-06-12">677240</value>
   <provider-org provider-activity-id="GB-GOV-10-GAMRIF-WP6-GARDP-2019-2022" ref="GB-GOV-10" type="10">
    <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Global Antibiotic Research &amp; Development Partnership (GARDP)</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-15"></transaction-date>
   <value currency="GBP" value-date="2020-12-15">2051474</value>
   <provider-org provider-activity-id="GB-GOV-10-GAMRIF-WP6-GARDP-2019-2022" ref="GB-GOV-10" type="10">
    <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Global Antibiotic Research &amp; Development Partnership (GARDP)</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="GBP" value-date="2021-03-23">1000000</value>
   <provider-org provider-activity-id="GB-GOV-10-GAMRIF-WP6-GARDP-2019-2022" ref="GB-GOV-10" type="10">
    <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Global Antibiotic Research &amp; Development Partnership (GARDP)</narrative>
   </receiver-org>
  </transaction>
  <related-activity ref="GB-GOV-10-GAMRIF-BACTIVAC" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP1-UK-CHINA" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP2-CARBX" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP3-InnoVet-AMR" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP4 - Argentina" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP5-FIND" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP6-GARDP" type="3"></related-activity>
 </iati-activity>
</iati-activities>
